Which drug wins? labetalol vs lignocaine for safer intubation in gallbladder surgery

NCT ID NCT07192081

Recruiting now Symptom relief Sponsor: Dr. Waseem Ullah Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether labetalol or lignocaine (lidocaine) is better at preventing sudden rises in heart rate and blood pressure when a breathing tube is inserted for gallbladder surgery. 116 adults having elective laparoscopic gallbladder removal will receive one of the two drugs before intubation. The goal is to see which keeps vital signs more stable, helping anesthesiologists choose the safer option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: labetalol and lignocaine (lidocaine)
What this could lead to: If one drug works better, it could become the preferred choice for keeping patients stable during intubation for gallbladder surgery.
What could go wrong: This is a small, early-stage trial (116 people) comparing two common drugs. Results may not apply to other surgeries or patients with health problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholelithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA HEMODYNAMIC RESPONSE TO LARYNGOSCOPY INTUBATION LAPAROSCOPIC CHOLECYSTECTOMY

Contacts and locations

Show contact details

Locations

Hayatabad Med Complex
RECRUITING

Peshawar, Khyber Pakhtunkhwa, 25000, Pakistan

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.